For the vaccination of healthy horses as an aid in the prevention of disease caused by Streptococcus equi.
Please note that this is a general product information according to US approvals, for specific regulatory information concerning your market please contact Regulatory department email: Regulatory.AffairsMER@zoetis.com
DOSE: Aseptically rehydrate with the entire contents of the accompanying sterile diluent. Instill the entire rehydrated vaccine into one nostril using a syringe with applicator tip. Administer a second dose 2 to 3 weeks later. Annual revaccination is recommended. FOR INTRANASAL USE ONLY. DO NOT ADMINISTER BY ANY ROUTE OTHER THAN INTRANASAL.
This product contains live bacteria and is designed for intranasal use only. Disinfect hands and equipment after use. Contamination of the user’s hands or equipment with reconstituted vaccine could lead to infections if proper disinfection practices are not followed prior to procedures that require asepsis. Injection equipment used to reconstitute or administer Pinnacle I.N. should not be reused, and should be disposed of appropriately. In case of anaphylactoid reaction, administer epinephrine. After administration a small number of horses may experience non-contagious transitory upper respiratory signs including nasal discharge and lymphadenectasis. Purpura hemorrhagica may be seen in hypersensitive individuals following exposure to streptococcal proteins. Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. Shake well after rehydration. Do not vaccinate within 30 days before slaughter. Use entire contents when first opened. Burn container and all unused contents